Leveraged long/short direct index tax-loss harvesting often underperforms selling and reinvesting once fees, taxes, and risk ...
As the Artemis II astronauts hurtled around the moon during their historic flyby, basking in unprecedented views of the illuminated lunar far side, pilot Victor Glover described the visuals as “sci-fi ...
The history of Databricks represents the evolution of large-scale data processing from academic research into a dominant industrial paradigm. This topic exists to provide context on how the "Lakehouse ...
Databricks has announced an $850 million investment in the United Kingdom over the next three years, significantly expanding its footprint and accelerating enterprise adoption of data and AI. The ...
NASA's Artemis II mission will send four astronauts on a 10-day journey around the moon, the first crewed mission toward the moon in over 50 years. The mission is scheduled to launch on April 1 from ...
Enterprise clients can now leverage Growth Protocol's reasoning engine directly within Databricks via an SDK, without moving any data. Growth Protocol is an enterprise reasoning platform that uses ...
Most enterprise RAG pipelines are optimized for one search behavior. They fail silently on the others. A model trained to synthesize cross-document reports handles constraint-driven entity search ...
Lipid nanoparticles (LNPs) have become the gold standard in non-viral gene delivery technologies, exemplified by the approval of the LNP messenger RNA (mRNA) vaccines against SARS-CoV-2. Since then, ...
. ├── CHANGELOG.md # Project changelog — version history and updates ├── CONTRIBUTING # Contribution guidelines (commits, PRs, conventions) ├── LICENCE # Project license and usage permissions ├── ...
Alzheimer’s disease (AD) is a progressive, neurodegenerative disease characterized by accumulation of beta-amyloid in extracellular plaques and tau protein in intracellular neurofibrillary tangles ...
LOWERING DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced nine new agreements with major pharmaceutical companies to lower prescription drug prices for Americans in line ...
Another day, another ambitious company emerges to harness the power of the Sun from Earth's orbit. Okay, it's not quite that common an occurrence, but there are indeed a number of firms giving this a ...